TRACK BRANDS ON AI
Monitor your brand, company, or product's online reputation in AI responses
Searching...
Loading...
It's taking longer than usual, we might be experiencing higher load.
Give it a few more seconds or try again in a moment.
Give it a few more seconds or try again in a moment.
Searching...
Loading...
What does AI know about Voyager Therapeutics Inc?
What does OpenAI free version (gpt-3.5-turbo) know about Voyager Therapeutics Inc?
Last request | 03.01.2024
(There is a high chance that below response is an AI hallucination) |
Well Known | No |
Description | Voyager Therapeutics Inc is a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases. |
Most Notable Achievements | Voyager Therapeutics Inc has a strong pipeline of gene therapies in development for neurological diseases. |
The Most Negative Fact | Voyager Therapeutics Inc has yet to bring any of its gene therapies to market. |
Competition | None |
Share with friends |
Register your email below to unlock features!
Don't like the AI answers? Who can help me Change them?
What does OpenAI paid version (gpt-4) know about Voyager Therapeutics Inc?
Request date | |
Well Known | No |
Description | Voyager Therapeutics Inc is a clinical-stage gene therapy company that focuses on developing treatments for severe neurological diseases. |
Most Notable Achievements | Voyager Therapeutics Inc has a strong pipeline of potential gene therapies for various neurological disorders. |
The Most Negative Fact | Voyager Therapeutics Inc has faced setbacks in clinical trials, including the discontinuation of a Parkinson's disease gene therapy program. |
Competition | None |
Share with friends |
What does Google AI (PaLM) know about Voyager Therapeutics Inc?
Last request | 03.01.2024 |
Well Known | yes |
Description | Voyager Therapeutics, Inc. is a clinical-stage gene therapy company focused on developing treatments for patients with severe genetic diseases. |
Most Notable Achievements | The company's lead product candidate, VY-AADC, is in Phase 2 clinical trials for the treatment of Parkinson's disease. |
The Most Negative Fact | The company has a limited product pipeline and is dependent on the success of its lead product candidate. |
Competition | None |
What does Microsoft Bing AI know about Voyager Therapeutics Inc?
Well Known | No |
Description | eatioy -rrguocedy noefet acno cd vpuahsra slaaennnemfTe iaismvirnrgeltieV-p l.ttiga cegclpliu fcag esodeos rhnescos ngneIg iees oleye pnieaahsctr |
Most Notable Achievements | fa pungrseitci ieehneilnr d u agfodoacco nI e ymsgnaee.rtroea n epnpisel evtpV oiTsrosselli areaehhet os gp |
The Most Negative Fact | tae oebr f trmyr sTiiuah n ntae rea.heeaytete itkasrg ssinoV c ch pIotp oneygg |
Competition | oNne |